Last Updated : September 7, 2018
Details
FilesGeneric Name:
Certolizumab pegol
Project Status:
Complete
Therapeutic Area:
Arthritis, psoriatic
Manufacturer:
UCB Canada Inc.
Call for patient/clinician input open:
Brand Name:
Cimzia
Project Line:
Reimbursement Review
Project Number:
SR0394-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC
Performance Metric:
Not achieved
Submission Type:
Initial
Indications:
Arthritis, psoriatic
Recommendation Type:
List with criteria/condition
Final Recommendation:
Files
Last Updated : September 7, 2018